140 related articles for article (PubMed ID: 26083214)
21. Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease.
Monteleone G; Fantini MC; Onali S; Zorzi F; Sancesario G; Bernardini S; Calabrese E; Viti F; Monteleone I; Biancone L; Pallone F
Mol Ther; 2012 Apr; 20(4):870-6. PubMed ID: 22252452
[TBL] [Abstract][Full Text] [Related]
22. Technology evaluation: ISIS-104838, OraSense.
Kennewell P
Curr Opin Mol Ther; 2003 Feb; 5(1):76-80. PubMed ID: 12669475
[TBL] [Abstract][Full Text] [Related]
23. A Novel
Di Fusco D; Marafini I; Stolfi C; Troncone E; Onali S; Lolli E; Caprioli F; Mazza S; Raffaella C; Manzo L; Borgiani P; Giuffrida P; Di Sabatino A; Monteleone I; Monteleone G
Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32707955
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide in oral Crohn's disease refractory to conventional medical treatment.
Odeka EB; Miller V
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):250-1. PubMed ID: 9252926
[No Abstract] [Full Text] [Related]
25. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporine for induction of remission in Crohn's disease.
McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
[TBL] [Abstract][Full Text] [Related]
27. Commentary: Individual vs. weight-based dosing of azathioprine in Crohn's disease.
Fraser AG
Aliment Pharmacol Ther; 2014 Feb; 39(4):438-9. PubMed ID: 24447314
[No Abstract] [Full Text] [Related]
28. Letter: metabolite monitoring for thiopurines in Crohn's disease - still not fully understood.
González Lama Y; Gisbert JP
Aliment Pharmacol Ther; 2014 Mar; 39(6):642. PubMed ID: 24588251
[No Abstract] [Full Text] [Related]
29. Super turbo azathioprine: can Crohn's disease healing be accelerated?
Robinson M
Am J Gastroenterol; 1996 Jun; 91(6):1273-4. PubMed ID: 8651193
[No Abstract] [Full Text] [Related]
30. A 24-year-old patient with Crohn's disease starting immunosuppressive therapy: vaccination issues to consider.
Wasan SK; Skolnik PR; Farraye FA
Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1013-6. PubMed ID: 20656060
[No Abstract] [Full Text] [Related]
31. Mycophenolate mofetil for Crohn's disease?
Lowry PW; Sandborn WJ; Lipsky JJ
Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
[No Abstract] [Full Text] [Related]
32. Methotrexate dose in current ECCO consensus on Crohn's disease.
Karaca C
J Crohns Colitis; 2010 Oct; 4(4):483. PubMed ID: 21122548
[No Abstract] [Full Text] [Related]
33. Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment.
Parker R; Dixit A; Fraser A; Creed TJ; Probert CS
Postgrad Med J; 2010 Apr; 86(1014):208-11. PubMed ID: 20354043
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
35. Early combined immunosuppression in Crohn's disease.
Herfarth H; Isaacs K
Lancet; 2008 Jun; 371(9629):1995-6; author reply 1996-7. PubMed ID: 18555904
[No Abstract] [Full Text] [Related]
36. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
Sandborn WJ; Tremaine WJ; Lawson GM
Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
[TBL] [Abstract][Full Text] [Related]
37. Hyperacute Methotrexate Pneumonitis in a Patient With Crohn's Disease.
Trivedi I; Raj R; Hanauer S
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):A29-30. PubMed ID: 26592712
[No Abstract] [Full Text] [Related]
38. Perioperative Management of Biologic and Immunosuppressive Medications in Patients With Crohn's Disease.
Lightner AL
Dis Colon Rectum; 2018 Apr; 61(4):428-431. PubMed ID: 29521822
[No Abstract] [Full Text] [Related]
39. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
Sandborn WJ
Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
[TBL] [Abstract][Full Text] [Related]
40. Topical tacrolimus for recurrent penile Crohn's disease.
Sánchez L; Cabanillas M; Alvarez JC; Echarri A
J Crohns Colitis; 2014 Oct; 8(10):1145-6. PubMed ID: 24815787
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
